Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

The compound was successfully made and shows potential for treating prostate cancer.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Hair loss in men is common, treatable, but not curable.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Flutamide-induced hypospadias in rats slows down early wound healing.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Estrogen therapy can reduce skin aging but has cancer risks.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.